The best way to beat cancer is to catch it early.
Advancing cancer screening with CDA technology and multi-disciplinary expertise.
Early cancer screening saves lives and dramatically reduces costs.
Co-Founder, Dr. Chris Yu and Dr. Herbert Yu are bringing together this multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts. Their unique, cross-disciplinary approach combines numerous fields of science, medicine and engineering to achieve our innovative, patented early cancer screening and detection technology.
Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.Read the full article
Anpac Bio has partnered with respected medical and research institutions in China and the U.S., conducting multiple research studies. Anpac Bio scientists have published and presented research studies at the American Society of Clinical Oncology (ASCO) and the World Nobel Prize Laureate Summit on Biomedical Sciences, among others.